{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:27:18Z","timestamp":1790476038737,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["CTP-79851"],"award-info":[{"award-number":["CTP-79851"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012419","name":"TRIUMF","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012419","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.expneurol.2013.03.021","type":"journal-article","created":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T08:34:54Z","timestamp":1364805294000},"page":"19-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: Behavior, positron emission tomography, immunohistochemistry"],"prefix":"10.1016","volume":"247","author":[{"given":"Scott","family":"Mackey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Dinelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris J.","family":"Doudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2013.03.021_bb0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2006.02.097","article-title":"Protective role of heat shock and heat shock protein 70 in lactacystin-induced cell death both in the rat substantia nigra and PC12 cells","volume":"1087","author":"Ahn","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0010","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/01.wnl.0000198511.09968.b3","article-title":"Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease","volume":"66","author":"Blandini","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2013.03.021_bb0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2013.03.021_bb0020","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/nen.0b013e318093e521","article-title":"Human retinal pigment epithelial cell implants ameliorate motor deficits in two rat models of Parkinson disease","volume":"66","author":"Cepeda","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nbd.2009.05.023","article-title":"Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions","volume":"35","author":"Chu","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0030","first-page":"505","article-title":"Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting","volume":"1\u201312","author":"Ciechanover","year":"2006","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.expneurol.2013.03.021_bb0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0896-6273(03)00606-8","article-title":"The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg","volume":"40","author":"Ciechanover","year":"2003","journal-title":"Neuron"},{"issue":"Suppl. 2","key":"10.1016\/j.expneurol.2013.03.021_bb0040","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1016\/j.parkreldis.2008.04.025","article-title":"Alpha-synuclein and autophagy as common steps in neurodegeneration","volume":"14","author":"Ferrucci","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0045","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1523\/JNEUROSCI.23-26-08955.2003","article-title":"Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition","volume":"23","author":"Fornai","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0050","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0969-8051(96)00213-2","article-title":"A simple synthesis of [11C]dihydrotetrabenazine (DTBZ)","volume":"24","author":"Jewett","year":"1997","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0060","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2967\/jnumed.107.040550","article-title":"Performance measurement of the microPET focus 120 scanner","volume":"48","author":"Kim","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0065","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ana.20935","article-title":"Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys","volume":"60","author":"Kordower","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/mds.21306","article-title":"Proteasome inhibitor model of Parkinson's disease in mice is confounded by neurotoxicity of the ethanol vehicle","volume":"22","author":"Landau","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0075","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/NEN.0b013e318186de64","article-title":"c-Jun N-terminal kinase mediates lactacystin-induced dopamine neuron degeneration","volume":"67","author":"Li","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0080","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00702-008-0027-6","article-title":"Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems","volume":"115","author":"MacInnes","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0085","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.20938","article-title":"Lack of nigrostriatal pathology in a rat model of proteasome inhibition","volume":"60","author":"Manning-Bog","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2007.06.076","article-title":"Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration","volume":"1168","author":"Mathur","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson's disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(02)00296-3","article-title":"Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease","volume":"326","author":"McNaught","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1471-4159.2002.00821.x","article-title":"Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures","volume":"81","author":"McNaught","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2013.03.021_bb9000","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/00001756-200208070-00018","article-title":"Proteasome inhibition causes nigral degeneration with inclusion bodies in rats","volume":"13","author":"McNaught","year":"2002","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2013.03.021_bb0110","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1046\/j.1460-9568.2002.02301.x","article-title":"Aggresome-related biogenesis of Lewy bodies","volume":"16","author":"McNaught","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/exnr.2002.8050","article-title":"Altered proteasomal function in sporadic Parkinson's disease","volume":"179","author":"McNaught","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.20186","article-title":"Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease","volume":"56","author":"McNaught","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2005.01.024","article-title":"Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition","volume":"380","author":"Miwa","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0130","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1093\/brain\/awp209","article-title":"Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study","volume":"132","author":"Nandhagopal","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2013.03.021_bb0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000202972","article-title":"Nigral degeneration with inclusion body formation and behavioral changes in rats after proteasomal inhibition","volume":"87","author":"Niu","year":"2009","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0140","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/mds.21013","article-title":"Ubiquitin-proteasome system and Parkinson's disease","volume":"21","author":"Olanow","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0145","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/brain\/awm318","article-title":"The role of autophagy\u2013lysosome pathway in neurodegeneration associated with Parkinson's disease","volume":"131","author":"Pan","year":"2008","journal-title":"Brain"},{"issue":"Suppl. 4","key":"10.1016\/j.expneurol.2013.03.021_bb0150","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S1353-8020(09)70830-2","article-title":"Does autophagy worsen or improve the survival of dopaminergic neurons?","volume":"15","author":"Pasquali","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2013.03.021_bb0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","article-title":"Non-motor symptoms in Parkinson's disease","volume":"15","author":"Poewe","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0160","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1471-4159.2005.03124.x","article-title":"Dopaminergic neurons in rat ventral midbrain cultures undergo selective apoptosis and form inclusions, but do not up-regulate iHSP70, following proteasomal inhibition","volume":"93","author":"Rideout","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0165","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature05291","article-title":"The roles of intracellular protein-degradation pathways in neurodegeneration","volume":"443","author":"Rubinsztein","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2013.03.021_bb0170","series-title":"The Behavior of the Laboratory Rat: A Handbook with Tests","first-page":"129","article-title":"Orienting and placing","author":"Schallert","year":"2005"},{"key":"10.1016\/j.expneurol.2013.03.021_bb0175","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.20934","article-title":"Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons","volume":"60","author":"Schapira","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0180","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/sj.jcbfm.9600446","article-title":"In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD","volume":"27","author":"Sossi","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0185","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2013.03.021_bb0190","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s11307-006-0051-6","article-title":"Evaluation of the integrity of the dopamine system in a rodent model of Parkinson's disease: small animal positron emission tomography compared to behavioral assessment and autoradiography","volume":"8","author":"Strome","year":"2006","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0195","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuro.2006.06.006","article-title":"Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models","volume":"27","author":"Sun","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2013.03.021_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-11-1","article-title":"Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease","volume":"11","author":"Vernon","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0197-4580(93)90112-O","article-title":"New stereological methods for counting neurons","volume":"14","author":"West","year":"1993","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2013.03.021_bb0210","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/cne.902780305","article-title":"Three-dimensional counting: an accurate and direct method to estimate numbers of cells in sectioned material","volume":"278","author":"Williams","year":"1988","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0215","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11064-009-0086-6","article-title":"Intrastriatal transplantation of GDNF-engineered BMSCs and its neuroprotection in lactacystin-induced Parkinsonian rat model","volume":"35","author":"Wu","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0220","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.20932","article-title":"Reproducible nigral cell loss after systemic proteasomal inhibitor administration to rats","volume":"60","author":"Zeng","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2013.03.021_bb0225","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1096\/fj.07-8386com","article-title":"Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators","volume":"21","author":"Zhu","year":"2007","journal-title":"FASEB J."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488613001143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488613001143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T05:13:09Z","timestamp":1588828389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488613001143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":46,"alternative-id":["S0014488613001143"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2013.03.021","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: Behavior, positron emission tomography, immunohistochemistry","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2013.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}